Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Thailand
      Biotech

      Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Thailand

      September 23, 2024
      Preclinical Research with Advanced Oncology Models and Immuno-oncology Services by Altogen Labs
      Biotech

      Preclinical Research with Advanced Oncology Models and Immuno-oncology Services by Altogen Labs

      September 21, 2024
      Henlius Receives Positive CHMP Opinion for HANSIZHUANG as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
      Biotech

      Henlius Receives Positive CHMP Opinion for HANSIZHUANG as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

      September 21, 2024
      FDA Roundup: September 20, 2024
      Biotech

      FDA Roundup: September 20, 2024

      September 21, 2024
      Rakuten Medical Presented Research Results of Preclinical Studies for PD-L1-Targeted Photoimmunotherapy at The 83rd Annual Meeting of The Japanese Cancer Association 2024
      Biotech

      Rakuten Medical Presented Research Results of Preclinical Studies for PD-L1-Targeted Photoimmunotherapy at The 83rd Annual Meeting of The Japanese Cancer Association 2024

      September 20, 2024
      UNION therapeutics to present orismilast Phase 2b results in atopic dermatitis as a late-breaking oral presentation at the EADV Congress 2024
      Biotech

      UNION therapeutics to present orismilast Phase 2b results in atopic dermatitis as a late-breaking oral presentation at the EADV Congress 2024

      September 20, 2024
      Renovos Biologics strengthens its Board’s US expertise with the appointment of Lisa Ferrara, Ph.D., as a Non-Executive Director
      Biotech

      Renovos Biologics strengthens its Board’s US expertise with the appointment of Lisa Ferrara, Ph.D., as a Non-Executive Director

      September 19, 2024
      Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology
      Biotech

      Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology

      September 19, 2024
      TFS HealthScience Unveils Mission to Empower Partners and Enrich Lives Worldwide
      Biotech

      TFS HealthScience Unveils Mission to Empower Partners and Enrich Lives Worldwide

      September 19, 2024
      Clarivate Announces 15th Annual Pharmavision India Conference Agenda
      Biotech

      Clarivate Announces 15th Annual Pharmavision India Conference Agenda

      September 18, 2024
      « 1 … 88 89 90 91 92 … 151 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026